The North America Dialysis Market would witness market growth of 5.1% CAGR during the forecast period (2018 – 2024). Dialysis is used in removing waste products such as urea and creatinine from the blood which is caused due to the inappropriate functioning of kidney. The process is useful for people suffering from chronic renal failures. The technique is mostly used in treating end-stage renal disease and during kidney transplantation. With the help of this process, blood is purified, excess fluids and toxins are removed, and electrolyte balance is restored in the blood. Dialysis is carried out in two ways namely, hemodialysis and peritoneal dialysis. In the hemodialysis method, the waste products such as urea are removed extra corporeally from the blood of the person. In the peritoneal dialysis method, the peritoneum in the abdomen is used for dialysis.

Based on End user, the market is segmented into In-Center Dialysis and Home Dialysis. Based on Products and Services, the, market is segmented into Services, equipment, Consumables and Drugs. Based on Type, the market is segmented into Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fresenius Medical Care Ag & Co. Kgaa, Baxter International, Inc., Davita Inc., Nipro Corporation, B. Braun Avitum Ag, Diaverum Deutschland Gmbh., Nikkiso Co. Ltd., Nxstage Medical, Inc., Cantel Medical Corporation (Medicators, Inc)., Asahi Kasei Corporation.